✦ LIBER ✦

Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14

✍ Scribed by Daniela Perotti; Giovanna De Vecchi; Maria A. Testi; Elena Lualdi; Piergiorgio Modena; Patrizia Mondini; Fernando Ravagnani; Paola Collini; Francesca Di Renzo; Filippo Spreafico; Monica Terenziani; Gabriella Sozzi; Franca Fossati-Bellani; Paolo Radice

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 201 KB
Volume: 24
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.20096

No coin nor oath required. For personal study only.

✦ Synopsis

Wilms tumor (WT) is a kidney malignancy of childhood characterized by highly heterogeneous genetic alterations. We previously reported the molecular and cytogenetic characterization of a WT (Case 30) carrying an interstitial deletion in chromosome 7p14 between markers D7S555 and D7S668. Loss of heterozygosity (LOH) analyses had revealed that this same region was lost in 8 out of 38 examined WTs, suggesting that the identified interval contains a putative tumor suppressor gene. To confirm this hypothesis, in this work, we analyzed an additional 35 WTs, four of which showed LOH in the region of interest. Furthermore, we were able to more accurately define the extension of the deletion in Case 30, mapping it within an interval not exceeding 390 kb, proximally to D7S555. To date, only a single expressed gene, POU6F2 (the POU domain, class 6, transcription factor 2; also known as RPF1), has been recognized in this interval. Sequencing of the gene in the 12 WTs showing LOH and in a corresponding numbers of WT cases without LOH, led to the identification of two germline nucleotide substitutions. The first occurred in the 5'-untranslated region, while the second caused an amino acid change in a glutamine repeat domain. These mutations, whose occurrence was not observed in more than 100 control subjects, were detected in two patients showing the loss of the constitutionally wild-type allele in tumor DNA. Together with the finding of the expression of the POU6F2 mouse homolog in both fetal and adult kidney, our observations suggest that the gene is a tumor suppressor and is involved in hereditary predisposition to WT.

📜 SIMILAR VOLUMES

Mutations/deletions of the WT1 gene, los

Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan

✍ Hisaya Nakadate; Kinji Yokomori; Naoki Watanabe; Takashi Tsuchiya; Takeshi Namik 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 110 KB 👁 2 views

## Incidence rates of Wilms' tumor (WT) markedly differ in East Asian and Caucasian children. In the present study, we examined WT1 deletions/mutations and loss of heterozygosity (LOH) on 11p and 11q in a large number of WTs and compared our findings with those from 4 series of Caucasian WTs. Inci

Loss of heterozygosity on chromosome 9 a

Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

✍ Françoise Muzeau; Jean François Fléjou; Gilles Thomas; Richard Hamelin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar

Somatic mutations of the lysyl oxidase g

Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors

✍ Katalin Csiszar; Sheri F.T. Fong; Aniko Ujfalusi; Stephen A. Krawetz; Eugene P. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 305 KB 👁 1 views

## Abstract Lysyl oxidase (LOX), a copper‐dependent amine oxidase, has been implicated in tumor suppression and cell growth regulation. The chromosomal locus of LOX, 5q23, is affected by loss of heterozygosity (LOH) in colon cancer, suggesting that the LOX gene could be affected by LOH and conseque

Loss of heterozygosity on chromosome 13q

Loss of heterozygosity on chromosome 13q12–q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors

✍ Esther Gras; Joan Cortes; Orland Diez; Carmen Alonso; Xavier Matias-Guiu; Montse 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Loss of heterozygosity and mutations are

Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma

✍ Kwong Wai Choy; Chi Pui Pang; Christopher B.O. Yu; Hing Lok Wong; Joan S.K. Ng; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

We investigated sequence alternation, promoter methylation, and loss of heterozygosity (LOH) of the RB1 gene as possible mechanisms of its inactivation in retinoblastoma. In 42 Chinese patients with sporadic retinoblastoma, the promoter and entire coding region of RB1 were examined for sequence chan

Loss of p53 in esophageal squamous cell

Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: Analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients

✍ Akinori Egashira; Masaru Morita; Rintaro Yoshida; Hiroshi Saeki; Eiji Oki; Noria 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB